Researchers used AI to map collagen “highways” and myeloid roadblocks that trap T cells in pancreatic ductal adenocarcinoma, targeting a key mechanistic barrier to immunotherapy. The work, described as a deep-learning approach to spatial immunobiology, links tumor microenvironment structure to immune exclusion. The study aims to clarify why therapies that expand T-cell presence often fail to generate effective tumor killing in pancreatic tumors. By identifying physical and cellular elements that regulate where T cells can traffic, the model provides a framework for identifying intervention points. For drug developers, the approach increases the feasibility of translating microenvironment features into measurable biomarkers or stratification rules. It also supports the design of combination strategies that target both immune activation and immune access. The report reinforces the momentum around spatial, multimodal modeling to convert histology and molecular patterns into immunotherapy-relevant hypotheses.